ResoTher Pharma A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About ResoTher Pharma A/S
ResoTher Pharma A/S (CVR number: 37852406K) is a company from RUDERSDAL. The company recorded a gross profit of 0 kDKK in 2024. The operating profit was -12.8 mDKK, while net earnings were -10.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was -70 %, which can be considered poor and Return on Equity (ROE) was -61.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 81.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. ResoTher Pharma A/S's liquidity measured by quick ratio was 5.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | |||||
EBIT | -7 084.00 | -12 717.00 | -30 799.00 | -19 878.00 | -12 825.00 |
Net earnings | -5 196.00 | -11 678.00 | -25 607.00 | -17 498.00 | -10 071.00 |
Shareholders equity total | - 560.00 | 38 631.00 | 13 784.00 | 20 760.00 | 12 122.00 |
Balance sheet total (assets) | 4 535.00 | 41 406.00 | 17 806.00 | 21 761.00 | 14 847.00 |
Net debt | 2 325.00 | -23 611.00 | -11 777.00 | -17 465.00 | -11 062.00 |
Profitability | |||||
EBIT-% | |||||
ROA | -134.0 % | -54.7 % | -104.0 % | -100.3 % | -70.0 % |
ROE | -166.4 % | -54.1 % | -97.7 % | -101.3 % | -61.3 % |
ROI | -165.0 % | -60.1 % | -117.4 % | -114.9 % | -78.0 % |
Economic value added (EVA) | -5 100.53 | -11 068.49 | -27 294.66 | -18 179.21 | -11 104.78 |
Solvency | |||||
Equity ratio | -11.0 % | 93.3 % | 77.4 % | 95.4 % | 81.6 % |
Gearing | -645.5 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 3.2 | 14.9 | 4.4 | 21.7 | 5.4 |
Current ratio | 3.2 | 14.9 | 4.4 | 21.7 | 5.4 |
Cash and cash equivalents | 1 290.00 | 23 611.00 | 11 777.00 | 17 465.00 | 11 062.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.